Authors:
SCHROEDER M
JASLOWSKI A
THOMAS A
WARREN T
LEWIS S
ESSELL J
HARMAN G
ALLERTON J
WILKS S
OSSWALD M
HALVORSON R
Citation: M. Schroeder et al., BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL, Blood, 88(10), 1996, pp. 3762-3762
Authors:
SHAUGHNESSY P
LEWIS S
ALLERTON J
SCHROEDER M
Citation: P. Shaughnessy et al., THE BILI DAY INDEX (BDI) - A SIMPLIFIED WAY TO PREDICT LIFE-THREATENING VENO OCCLUSIVE DISEASE (VOD) ALLOGENIC BONE-MARROW TRANSPLANT (BMT)PATIENTS, Blood, 88(10), 1996, pp. 3763-3763
Citation: K. Raybon et al., INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF), Blood, 86(10), 1995, pp. 3270-3270
Authors:
RAYBON K
THOMAS A
SCHROEDER M
LEWIS S
CHRISTMAN K
WILKS S
OSSWALD M
ABBOTT K
HALVORSON R
ESSELL J
ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833
Authors:
SHAUGHNESSY P
LEWIS S
SCHROEDER M
ALLERTON J
WILKS S
CHRISTMAN K
OSSWALD M
ABBOTT K
HARMON G
HALVORSON R
SNYDER M
CALLANDER N
Citation: P. Shaughnessy et al., BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG), Blood, 86(10), 1995, pp. 3849-3849
Citation: M. Osswald et al., A STUDY OF MIDCOUNTS AS PREDICTORS OF FINAL YIELD DURING THE HARVEST OF BONE-MARROW FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 3947-3947
Authors:
BANE C
HALVORSON R
SCHROEDER M
CALLANDER N
ALLERTON J
SNYDER M
WILKS S
CHRISTMAN K
LEWIS S
HARMAN G
Citation: C. Bane et al., ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE, Blood, 84(10), 1994, pp. 10000704-10000704
Authors:
SCHROEDER M
ESSELL J
HARMAN G
HALVORSON R
DOLAN M
CALLANDER N
SNYDER M
WILKS S
ALLERTON J
THOMPSON J
Citation: M. Schroeder et al., DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000425-10000425
Authors:
WILKS S
ESSELL J
MCGLASSON D
HARMAN G
HALVORSON R
CALLANDER N
SNYDER M
ALLERTON J
Citation: S. Wilks et al., DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD), Blood, 82(10), 1993, pp. 10000623-10000623